Properties (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Actelion
Merial |
| gptkbp:businessModel |
research-driven
|
| gptkbp:CEO |
gptkb:Hubertus_von_Baumbach
|
| gptkbp:clinicalTrials |
conducts thousands annually
|
| gptkbp:employees |
approximately 50,000
|
| gptkbp:focus_area |
diabetes
neurology oncology animal health products cardiovascular diseases infectious diseases immunology respiratory diseases |
| gptkbp:founded |
1885
|
| gptkbp:founder |
gptkb:Albert_Boehringer
|
| gptkbp:global_presence |
over 150 countries
|
| gptkbp:headCoach |
50,000+
|
| gptkbp:headquarters |
gptkb:Ingelheim,_Germany
Ingelheim_am_Rhein,_Germany |
| https://www.w3.org/2000/01/rdf-schema#label |
Boehringer Ingelheim
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:investmentFocus |
approximately €3 billion
|
| gptkbp:market |
global pharmaceutical market
|
| gptkbp:partnerships |
gptkb:Eli_Lilly
gptkb:Bristol-Myers_Squibb gptkb:Pfizer Sanofi AbbVie |
| gptkbp:patentCitation |
thousands of patents filed
|
| gptkbp:philosophy |
sustainable development goals
collaboration with healthcare professionals commitment to patients responsibility towards society value of innovation |
| gptkbp:products |
prescription medications
|
| gptkbp:research_focus |
animal health
human pharmaceuticals |
| gptkbp:revenue |
approximately €19 billion
|
| gptkbp:social_responsibility |
community engagement
environmental protection education initiatives sustainability initiatives healthcare_access |
| gptkbp:subsidiary |
gptkb:Boehringer_Ingelheim_Pharmaceuticals
gptkb:Boehringer_Ingelheim_Animal_Health |
| gptkbp:website |
www.boehringer-ingelheim.com
|